Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder
Status:
Completed
Trial end date:
2019-09-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if TAR-302-5018, an investigational drug-delivery
system, is safe and tolerable in patients with idiopathic overactive bladder and urinary
incontinence.